Chairman Appointed for Horizon

Horizon Discovery has appointed Dr. Ian Gilham as Chairman of its Board of Directors.

Dr. Gilham’s healthcare industry career spans thirty years encompassing all aspects of successful company growth and development. He was Chief Executive Officer of Axis-Shield plc, prior to its sale to Alere and he has also held top management positions at GSK, Abbott Laboratories, Celltech and Amersham, gaining wide expertise in the fields of pharmaceuticals and clinical diagnostics.

Dr. Gilham is currently non-executive Chairman of Multiplicom, focused on the development and commercialisation of innovative molecular genetic tests; and Biosurfit SA, focused on development and commercialisation of point-of-care diagnostic products.

Dr. Gilham said: “I believe Horizon Discovery is one of the World’s most innovative and promising life science organisations and I am very excited to continue to support the Company as Chairman. I am looking forward to working with the team during the next stages of the Company’s growth and development."